PREDIX HER2 trial: Event-free survival and pathologic complete response in clinical subgroups and stromal TILs levels
Hatschek, T., Andersson, A., Bjöhle, J., Bosch, A., Carlsson, L., Dreifaldt, Ann Charlotte, Einbeigi, Z., Elinder, E., Fredholm, H., Isaksson-Friman, E., Hellström, M., Johansson, H., Lekberg, T., Lindman, H., Zerdes, I., Foukakis, T., Hartman, J., Brandberg, Y., Bergh, J.
Published in ANNALS OF ONCOLOGY (2020)
Published in ANNALS OF ONCOLOGY (2020)
Get full text
Journal Article
Conference Proceeding
Immune function and response to neoadjuvant chemotherapy in hormone receptor positive, HER2-negative breast cancer
Matikas, A., Lövrot, J., Ramberg, A., Eriksson, M., Lindsten, T., Lekberg, T., Hedenfalk, I., Loman, N., Bergh, J., Erlandsson, A., Hatschek, T., Foukakis, T.
Published in ANNALS OF ONCOLOGY (2017)
Published in ANNALS OF ONCOLOGY (2017)
Get full text
Journal Article
Conference Proceeding
Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer
Matikas, A., Wang, K., Lagoudaki, E., Acs, B., Zerdes, I., Hartman, J., Azavedo, E., Bjöhle, J., Carlsson, L., Einbeigi, Z., Hedenfalk, I., Hellström, M., Lekberg, T., Loman, N., Saracco, A., von Wachenfeldt, A., Rotstein, S., Bergqvist, M., Bergh, J., Hatschek, T., Foukakis, T.
Published in ESMO open (01.04.2021)
Published in ESMO open (01.04.2021)
Get full text
Journal Article
Age-specific trends of survival in metastatic breast cancer: Data from a population-based cancer registry in Stockholm, Sweden
Foukakis, T., Fornander, T., Lekberg, T., Hellborg, H., Adolfsson, J., Bergh, J.
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2010)
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2010)
Get full text
Journal Article
Conference Proceeding
Five-Year Results of the Preoperative Accelerated Partial Breast Irradiation (PAPBI) Trial
Bosma, Sophie C.J., Leij, Femke, Vreeswijk, Sandra, Maaker, Michiel de, Wesseling, Jelle, Vijver, Marc van de, Scholten, Astrid, Rivera, Sofia, Bourgier, Celine, Auzac, Guillaume, Foukakis, Theodoros, Lekberg, Tobias, Bongard, Desiree, Loo, Claudette, Rutgers, Emiel, Bartelink, Harry, Elkhuizen, Paula H.M.
Published in International journal of radiation oncology, biology, physics (01.04.2020)
Published in International journal of radiation oncology, biology, physics (01.04.2020)
Get full text
Journal Article
Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas, Alexios, Johansson, Hemming, Grybäck, Per, Bjöhle, Judith, Acs, Balazs, Boyaci, Ceren, Lekberg, Tobias, Fredholm, Hanna, Elinder, Ellinor, Margolin, Sara, Isaksson-Friman, Erika, Bosch, Ana, Lindman, Henrik, Adra, Jamila, Andersson, Anne, Agartz, Susanne, Hellström, Mats, Zerdes, Ioannis, Hartman, Johan, Bergh, Jonas, Hatschek, Thomas, Foukakis, Theodoros
Published in Clinical cancer research (01.02.2023)
Published in Clinical cancer research (01.02.2023)
Get full text
Journal Article
The Impact of a Hepatobiliary Multidisciplinary Team Assessment in Patients with Colorectal Cancer Liver Metastases: A Population‐Based Study
Engstrand, Jennie, Kartalis, Nikolaos, Strömberg, Cecilia, Broberg, Mats, Stillström, Anna, Lekberg, Tobias, Jonas, Eduard, Freedman, Jacob, Nilsson, Henrik
Published in The oncologist (Dayton, Ohio) (01.09.2017)
Published in The oncologist (Dayton, Ohio) (01.09.2017)
Get full text
Journal Article
Combined assessment of metabolic response and tumor infiltrating lymphocytes as a predictor of outcomes following neoadjuvant therapy for HER2-positive breast cancer: Results from the randomized PREDIX HER2 trial
Matikas, Alexios, Johansson, Hemming, Grybäck, Per, Bjöhle, Judith, Lekberg, Tobias, Fredholm, Hanna, Acs, Balazs, Elinder, Ellinor, Isaksson-Friman, Erika, Agartz, Susanne, Hellstrom, Mats, Zerdes, Ioannis, Hartman, Johan, Bergh, Jonas C. S., Hatschek, Thomas, Foukakis, Theodoros
Published in JOURNAL OF CLINICAL ONCOLOGY (01.06.2022)
Published in JOURNAL OF CLINICAL ONCOLOGY (01.06.2022)
Get full text
Journal Article
Conference Proceeding
97O PREDIX HER2 trial: Event-free survival and pathologic complete response in clinical subgroups and stromal TILs levels
Hatschek, T., Andersson, A., Bjöhle, J., Bosch, A., Carlsson, L., Dreifaldt, A.C., Einbeigi, Z., Elinder, E., Fredholm, H., Isaksson-Friman, E., Hellström, M., Johansson, H., Lekberg, T., Lindman, H., Zerdes, I., Foukakis, T., Hartman, J., Brandberg, Y., Bergh, J.
Published in Annals of oncology (01.05.2020)
Published in Annals of oncology (01.05.2020)
Get full text
Journal Article
Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden
Foukakis, Theodoros, Fornander, Tommy, Lekberg, Tobias, Hellborg, Henrik, Adolfsson, Jan, Bergh, Jonas
Published in Breast cancer research and treatment (01.11.2011)
Published in Breast cancer research and treatment (01.11.2011)
Get full text
Journal Article
Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical Trial
Hatschek, Thomas, Foukakis, Theodoros, Bjöhle, Judith, Lekberg, Tobias, Fredholm, Hanna, Elinder, Ellinor, Bosch, Ana, Pekar, Gyula, Lindman, Henrik, Schiza, Aglaia, Einbeigi, Zakaria, Adra, Jamila, Andersson, Anne, Carlsson, Lena, Dreifaldt, Ann Charlotte, Isaksson-Friman, Erika, Agartz, Susanne, Azavedo, Edward, Grybäck, Per, Hellström, Mats, Johansson, Hemming, Maes, Claudia, Zerdes, Ioannis, Hartman, Johan, Brandberg, Yvonne, Bergh, Jonas
Published in JAMA oncology (01.09.2021)
Published in JAMA oncology (01.09.2021)
Get more information
Journal Article
Assessment of early response biomarkers in relation to long‐term survival in patients with HER2‐negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: Results from the Phase II PROMIX trial
Kimbung, Siker, Markholm, Ida, Bjöhle, Judith, Lekberg, Tobias, von Wachenfeldt, Anna, Azavedo, Edward, Saracco, Ariel, Hellström, Mats, Veerla, Srinivas, Paquet, Eric, Bendahl, Pär‐Ola, Fernö, Mårten, Bergh, Jonas, Loman, Niklas, Hatschek, Thomas, Hedenfalk, Ingrid
Published in International journal of cancer (01.02.2018)
Published in International journal of cancer (01.02.2018)
Get full text
Journal Article
One-year follow-up of health-related quality of life in the Swedish PREDIX HER 2 trial, evaluating docetaxel, trastuzumab sc, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2 positive breast cancer
Brandberg, Yvonne, Foukakis, Theodoros, Andersson, Anne, Bjohle, Judith, Bosch, Ana, Carlsson, Lena, Einbeigi, Zakaria, Fredholm, Hanna, Isaksson-Friman, Erika, Hellstrom, Mats, Johansson, Hemming, Lekberg, Tobias, Lindman, Henrik, Bergh, Jonas C. S., Hatschek, Thomas
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2020)
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2020)
Get full text
Journal Article
Conference Proceeding
First results of the preoperative accelerated partial breast irradiation (PAPBI) trial
van der Leij, Femke, Bosma, Sophie C.J, van de Vijver, Marc J, Wesseling, Jelle, Vreeswijk, Sandra, Rivera, Sofia, Bourgier, Celine, Garbay, Jean-Rémi, Foukakis, Theodoros, Lekberg, Tobias, van den Bongard, Desiree H.J.G.D, van Vliet-Vroegindeweij, Corine, Bartelink, Harry, Rutgers, Emiel J, Elkhuizen, Paula H.M
Published in Radiotherapy and oncology (01.03.2015)
Published in Radiotherapy and oncology (01.03.2015)
Get full text
Journal Article
Docetaxel, trastuzumab, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2-positive breast cancer: Results from the Swedish PREDIX HER2 trial identifying a new potential de-escalation standard?
Bergh, Jonas C. S., Andersson, Anne, Bjohle, Judith, Bosch, Ana, Carlsson, Lena, Dreifaldt, Ann Charlotte, Einbeigi, Zakaria, Fredholm, Hanna, Isaksson-Friman, Erika, Foukakis, Theodoros, Elinder, Ellinor, Hellstrom, Mats, Johansson, Hemming, Lekberg, Tobias, Lindman, Henrik, Maes, Claudia, Brandberg, Yvonne, Hatschek, Thomas
Published in JOURNAL OF CLINICAL ONCOLOGY (2019)
Published in JOURNAL OF CLINICAL ONCOLOGY (2019)
Get full text
Journal Article
Conference Proceeding
Health-related quality of life in the Swedish PREDIX HER2 trial, evaluating docetaxel, trastuzumab, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2-positive breast cancer
Brandberg, Yvonne, Andersson, Anne, Bjohle, Judith, Bosch, Ana, Carlsson, Lena, Dreifaldt, Ann Charlotte, Einbeigi, Zakaria, Fredholm, Hanna, Isaksson-Friman, Erika, Foukakis, Theodoros, Elinder, Ellinor, Hellstrom, Mats, Johansson, Hemming, Lekberg, Tobias, Lindman, Henrik, Bergh, Jonas C. S., Hatschek, Thomas
Published in JOURNAL OF CLINICAL ONCOLOGY (2019)
Published in JOURNAL OF CLINICAL ONCOLOGY (2019)
Get full text
Journal Article
Conference Proceeding
Abstract P5-14-05: Preoperative accelerated partial breast irradiation (PAPBI) trial: First results on acute toxicity, complications and cosmetic results
van der Leij, F, Bartelink, H, Rutgers, E, Rivera, S, van den Bongard, D, Lekberg, T, Elkhuizen, P
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article
Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer
Matikas, Alexios, Lövrot, John, Ramberg, Anna, Eriksson, Margareta, Lindsten, Therese, Lekberg, Tobias, Hedenfalk, Ingrid, Loman, Niklas, Bergh, Jonas, Hatschek, Thomas, Erlandsson, Ann, Foukakis, Theodoros
Published in Oncoimmunology (01.01.2018)
Published in Oncoimmunology (01.01.2018)
Get full text
Journal Article
Abstract OT2-1-03: Preoperative accelerated partial breast irradiation trial (PAPBI); defining radiosensitivity
Elkhuizen, PHM, Bartelink, H, van de Vijver, M, Rutgers, E, Loo, C, Vogel, W, Rivera, S, Lekberg, T, van den Bongard, D
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article